Lv4
404 积分 2025-06-18 加入
Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degraders for Treating Inflammatory Diseases: Advances and Prospects
1天前
已完结
Psoriasis
1天前
已完结
Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics
1天前
已完结
Discovery of Rigid Linker-Based IRAK4 PROTACs with Improved Metabolic Stability for the Treatment of Inflammatory Diseases
1天前
已完结
Modelling atopic dermatitis in healthy human skin for the characterization of topical compounds
1天前
已完结
Topically Applied Therapies for the Treatment of Skin Disease: Past, Present, and Future
1天前
已完结
Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases
1天前
已完结
Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies
1天前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
1天前
已完结
Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials
1天前
已完结
皖公网安备34019202002308
